Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganisms causing bacteremia.
The in vitro activity of lomefloxacin, a new fluorinated quinolone antimicrobial, was compared to that of enoxacin, norfloxacin, ofloxacin, imipenem, cefotaxime, ceftazidime, and tobramycin against 597 microorganisms isolated from bacteremic patients at a university hospital. Overall, lomefloxacin had activity similar to that of enoxacin and norfloxacin but less than that of ofloxacin. Lomefloxacin had excellent activity against members of the family Enterobacteriaceae and Haemophilus influenzae, and good activity against staphylococci, including oxacillin-resistant strains, as well as many strains of Pseudomonas aeruginosa, P. maltophilia, and Acinetobacter calcoaceticus anitratus ssp anitratus.
Weinstein
M P
MP
Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901-0019.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D002439:Cefotaxime / Q000494:pharmacology; D002442:Ceftazidime / Q000494:pharmacology; D015365:Enoxacin / Q000494:pharmacology; D024841:Fluoroquinolones; D006801:Humans; D015378:Imipenem / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009643:Norfloxacin / Q000494:pharmacology; D015363:Quinolones; D018805:Sepsis / Q000382:microbiology*; D014031:Tobramycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D015363:Quinolones; D015365:Enoxacin; D015378:Imipenem; D002442:Ceftazidime; C053091:lomefloxacin; D009643:Norfloxacin; D002439:Cefotaxime; D014031:Tobramycin